Condition: Multisystem Inflammatory Syndrome in Children (MIS-C) · SARS-CoV-2 Infection · Sponsor: Medical University of Warsaw
Multisystem inflammatory syndrome in children (MIS-C) is a severe complication associated with SARS-CoV-2 infection that frequently affects the cardiovascular system. Although acute cardiac abnormalities usually resolve, the long-term cardiovascular consequences of MIS-C remain uncertain. Previous follow-up of this cohort 2 years after MIS-C identified signs of subclinical cardiovascular abnormalities compared with healthy controls. This cross-sectional study aims to evaluate cardiovascular health in individuals 5 years after MIS-C. Participants with a history of MIS-C will be compared with age- and sex-matched healthy controls using cardiovascular imaging, vascular assessments, cardiopulmonary exercise testing, and biomarkers of endothelial injury.
This description comes directly from the study's public registry record.
Weronika Woźniak-Szewczyk, MD · +48 22 317 9231 · wwozniakszewczyk@gmail.com
Magdalena Okarska-Napierała, MD PhD · +48 22 317 9231 · magdalena.okarska-napierala@wum.edu.pl
Always discuss trial participation with your own doctor first.
| Medical University of Warsaw Children's Clinical Hospital | Warsaw, Masovian Voivodeship, Poland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07659847